Antrinkos Andrew Aristidou

age:

56 years

appointments:

25 active

23 prior

primary industry:

Financial service activities, except insurance and pension funding

about Antrinkos

Since 2019, Aristidou has been a director of 48 companies, the current directorship have a combined turnover of approximately £7.1b.

Combined Valuation

£166.5b

Combined Turnover

£7.1b

active directorships over time

company
turnover
valuation
start
end
status
role
consumer healthcare holdings limited£0£48bSep 2019-OpenDirector
haleon uk services limited£752.5m£47.4bAug 2019-OpenDirector
haleon uk enterprises limited£0£34.7bSep 2019-OpenDirector
consumer healthcare intermediate holdings limited£0£19.4bSep 2019-OpenDirector
haleon uk trading limited£1.1b£4.5bAug 2019-OpenDirector
haleon uk ip limited£171.7m£3bAug 2019-OpenDirector
haleon uk trading services limited£4.3b£2.7bAug 2019-OpenDirector
kyowa kirin services ltd£346.8m£2.5bSep 2020-OpenDirector
haleon uk holding canada limited£0£1.4bDec 2019-OpenDirector
haleon uk finance limited£0£1bAug 2019-OpenDirector
kyowa kirin international plc£0£725.9mDec 2020-OpenDirector
haleon uk ip (no. 2) limited£0£505.7mAug 2019-OpenDirector
haleon uk export limited£262.6m£355.2mMar 2020-OpenDirector
kyowa kirin limited£75.4m£105.2mSep 2020-OpenDirector
haleon uk research limited£1.1m£50.8mAug 2019-OpenDirector
haleon uk holding sri lanka limited£0£47.4mAug 2019-OpenDirector
glaxosmithkline consumer healthcare (uk) (no.1) limited£0£23.6mAug 2019-OpenDirector
kyowa kirin pharmaceutical development limited£12.5m£14.8mSep 2020-OpenDirector
haleon uk holding new zealand limited£0£13.7mDec 2019-OpenDirector
archimedes pharma uk limited£0-Sep 2023-OpenDirector
kyowa kirin international holdco ltd--Nov 2022-OpenDirector
kki grunenthal uk holdco ltd--Nov 2022-OpenDirector
glaxosmithkline consumer healthcare investments (ireland) (no 3) limited--Aug 2019-OpenDirector
glaxosmithkline consumer healthcare investments (ireland) (no.2) unlimited company£23.6m-Aug 2019-OpenDirector